JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taylor, S. V.
Right arrow Articles by Begley, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, S. V.
Right arrow Articles by Begley, T. P.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 26, 16555-16560, June 26, 1998


Thiamin Biosynthesis in Escherichia coli
IDENTIFICATION OF ThiS THIOCARBOXYLATE AS THE IMMEDIATE SULFUR DONOR IN THE THIAZOLE FORMATION*

Sean V. Taylor, Neil L. Kelleher, Cynthia Kinsland, Hsiu-Ju Chiu, Colleen A. Costello, Allyson D. Backstrom, Fred W. McLafferty, and Tadhg P. BegleyDagger

From the Department of Chemistry, Cornell University, Baker Laboratory, Ithaca, New York 14853

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

ThiFSGH and ThiI are required for the biosynthesis of the thiazole moiety of thiamin in Escherichia coli. The overproduction, purification, and characterization of ThiFS and the identification of two of the early steps in the biosynthesis of the thiazole moiety of thiamin are described here. ThiS isolated from E. coli thiI+ is post-translationally modified by converting the carboxylic acid group of the carboxyl-terminal glycine into a thiocarboxylate. The thiI gene plays an essential role in the formation of the thiocarboxylate because ThiS isolated from a thiI- strain does not contain this modification. ThiF catalyzes the adenylation by ATP of the carboxyl-terminal glycine of ThiS. This reaction is likely to be involved in the activation of ThiS for sulfur transfer from cysteine or from a cysteine-derived sulfur donor.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The thiamin biosynthetic pathway in Escherichia coli is outlined in Fig. 1 (1-3). This pathway involves the separate synthesis of the thiazole (5-methyl-4-(beta -hydroxyethyl)thiazole phosphate) and the pyrimidine (4-amino-5-hydroxymethylpyrimidine pyrophosphate) moieties, which are then coupled to give thiamin phosphate. The pyrimidine is derived from 5aminoimidazole ribotide (4-7). The thiazole is derived from tyrosine (8-10), cysteine (11, 12), and 1-deoxy-D-xylulose-5-phosphate1 (13, 14). The mechanistic enzymology of the thiazole and the pyrimidine formation is still poorly understood. A five gene operon (thiCEFGH) involved in thiamin biosynthesis has been cloned and characterized (GenBankTM accession number U00006; Ref. 15).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1.   The generally accepted pathway for thiamin biosynthesis in E. coli. Salvage pathways are not shown.

The thiC gene complements pyrimidine (4-amino-5-hydroxymethylpyrimidine) requiring mutants, the thiFGH genes complement thiazole-requiring mutants, and thiE codes for thiamin phosphate synthase (16). An additional gene (thiI) required for thiazole biosynthesis in Salmonella typhimurium has recently been identified (17). This gene maps at 9.5 min on the E. coli chromosome and complements a nuvC mutation.2,3 NuvC is required for the biosynthesis of thiouridine in tRNA (18) as well as the thiazole moiety of thiamin (19) (Fig. 2). This suggests that ThiI may play a role in the sulfur transfer chemistry involved in the thiazole biosynthesis.


View larger version (9K):
[in this window]
[in a new window]
 
Fig. 2.   Proposed conversion of tRNA uridine to 4-thiouridine. The uridine at position 8 in tRNA is converted to 4-thiouridine.

When the gene product, originally assigned as ThiG, was purified from an overexpression strain, mass spectrometry and Edman sequencing both demonstrated that the protein consisted of two subunits. One of the subunits, which we will call ThiS, has a mass of 7310.74 Da. The second subunit, which will retain the ThiG name, has a mass of 26896.5 Da.4 Although the anomalous mass of ThiG was previously noted (15), ThiS was missed in the original reading frame assignment because of errors in both published sequences (15, 21) and also because of the difficulty of detecting ThiS, which stains poorly with Coomassie Blue and migrates at the dye front during normal SDS-PAGE5 analysis. The carboxyl terminus of ThiS has the -Gly-Gly sequence found at the carboxyl terminus of human erythrocyte ubiquitin (GenBankTM accession number 1070588). This sequence similarity was striking because ThiF shows significant sequence similarity to the ubiquitin-activating enzyme (GenBankTM accession number 731039) including the ATP-binding site. This suggested that ThiF might catalyze the adenylation of ThiS and that ThiS-COAMP might react with cysteine (or a cysteine-derived sulfur donor) to give ThiS-COSH (Fig. 3). In addition, the dual role of ThiI in thiazole and in 4-thiouridine biosynthesis suggested that ThiI might play a role in this sulfur transfer reaction. In this paper, we describe experiments to test these hypotheses.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 3.   The ubiquitin activation system and the proposed mechanism for formation of ThiS-COSH. A, reactions catalyzed by the ubiquitin-activating enzyme. The protein structure of ubiquitin is abbreviated to show only the COOH-terminal carboxylate portion. The protein structure of the ubiquitin-activating enzyme is abbreviated to show only the thiol of the active site cysteine. B, proposed sulfur transfer mechanism in thiazole biosynthesis.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

LB broth was purchased in dehydrated form from Life Technologies, Inc. Tryptose blood agar base was purchased from Difco (Detroit, MI). Ampicillin and isopropyl-beta -D-thiogalactopyranoside were from Jersey Lab and Glove Supply (Livingston, NJ). Tris, DTT, EDTA, (NH4)2SO4, and ATP were from Sigma. Sodium chloride was from Fisher (Pittsburgh, PA). Acetic acid and MeOH were from Aldrich. Acrylamide/Bis (37.5:1) was purchased from Bio-Rad. Dialysis membrane was from Spectrum (Houston, TX). All buffers were prepared from distilled, deionized water and were filtered through Millipore type HA 0.45-µm filters before use. WizardTM PCR preps were purchased from Promega (Madison, WI). BL21(DE3) and the lambda DE3 Lysogenization kit were purchased from Novagen (Madison, WI).

Protein purifications were performed on a Waters 650 chromatography instrument (Milford, MA). Gel filtration column (Superdex 75) was from Amersham Pharmacia Biotech. Reverse-phase mass spectrometric preparations were on Michrom BioResources (Auburn, CA) reverse-phase peptide traps. Protein concentration was assayed using Coomassie Plus protein assay reagent from Pierce. Concentrations were calibrated against a standard curve generated using bovine serum albumin. SDS-PAGE gels were prepared and run using standard methods (22). Pyrophosphate assays were conducted using the Enz-Chek pyrophosphate assay kit from Molecular Probes Inc. (Eugene, OR).

Mass values reported correspond to the most abundant isotopic peak (the difference in 1.0034 Da units from the monoisotopic peak is given in italics following the value). All spectra were calibrated externally using bovine ubiquitin as standard (8564.64 -5).

Construction of thiI- Strain, VJS2890-- A nuvC E. coli B strain was supplied by Hans Bremer (Dept. of Molecular Cell Biology, University of Texas, Dallas, TX). This strain is equivalent to the original nuvC strain, RYH101, described by Ryals et al. (19). Plasmid pVJS728, which was able to complement this nuvC mutant, was isolated from an E. coli K-12 HindIII library in pHG165 (23). The thiI456::Km (E. coli K-12) mutation was constructed by inserting a kanamycin cassette into the PstI site of pVJS728. This was back crossed to the E. coli chromosome by recombination in the sbcBC strain VJS2889 (24, 25). Genetic crosses were performed via bacteriophage P1 kc-mediated transduction (26).

Phenotype Analysis of VJS2890-- The VJS2890 strain was tested for growth with 5-methyl-4-(beta -hydroxyethyl)thiazole and screened for UV sensitivity (nuvC+ phenotype). VJS2890 was grown in thiamin-limiting defined medium supplemented with 0.2% glucose (26) and then plated as a lawn on defined medium. 1 µl of 100 µM 5-methyl-4-(beta -hydroxyethyl)thiazole was spotted on the plate, and growth around or between the 5-methyl-4-(beta -hydroxyethyl)thiazole spots was determined after overnight incubation at 37 °C. UV sensitivity was determined as described previously by Ryals et al. (19).

Construction of thiI- Overexpression Strain, VJS2890(DE3)-- Site-specific integration of the lambda DE3 prophage into the chromosome of the ThiI mutant, VJS2890, was accomplished using the lambda DE3 lysogenization kit (Novagen). The basal and induced expression levels of T7 RNA polymerase in a representative set of 12 lysogens were tested following the protocol provided with the kit. The lysogen (VJS2890(DE3)) that showed the lowest level of basal expression and a high level of isopropyl-beta -D-thiogalactopyranoside-induced expression of T7 RNA polymerase was chosen for use as an overexpression strain.

Construction of the ThiFS Overexpression Vector-- The 3 base pairs immediately upstream of the ThiF start codon on plasmid pVJS716 (15) were mutated to insert an NdeI site (CATATG) using PCR. The 5' primer was 5'-CT GGA AAT TGC AGG AGT TGC ATA TG ATG ACC GTG ACT TTA-3' and the 3' primer was 5'-CCA GAT AGC CAC TGG CGG-3'. The desired 1.8-kilobase pair fragment was purified using WizardTM PCR preps (Promega) and the NdeI/SalI fragment cloned into the corresponding sites on pET-22b (Novagen) to yield plasmid pG201. The MscI/SalI fragment (549 base pairs) was exchanged with the corresponding DNA from pVJS720 (15). A representative plasmid was named pCAC111. The remaining PCR-derived DNA (520 base pairs) was sequenced, and no mutations were observed.

Overexpression and Purification of ThiFS from E. coli BL21(DE3) (thiI+)-- Plasmid pCAC111 was transformed into E. coli strain BL21(DE3), and transformants were selected on tryptose blood agar plates containing ampicillin (200 µg/ml). A single colony of E. coli containing pCAC111 was grown at 37 °C for 12 h in 3 ml of LB broth supplemented with ampicillin (200 µg/ml); 1 ml of this starter culture was diluted into 1 liter of the same medium and grown to an A595 of approximately 0.6. Expression was induced by adding isopropyl-beta -D-thiogalactopyranoside to a final concentration of 0.3 mM, and growth was continued at 37 °C for 12 h. Cells were harvested by centrifugation (8000 × g, 30 min) and stored at -70 °C. A frozen cell pellet from 1 liter of cell culture was thawed and resuspended in 25 ml of loading buffer (50 mM Tris, 2 mM DTT, 2 mM EDTA, pH 7.5), treated with lysozyme (5 mg, 40 min, 4 °C), sonicated at 4 °C for 4 min, and centrifuged (27,000 × g, 15 min). The resulting cell free lysate was taken to 20% (NH4)2SO4 saturation at 4 °C by slow addition of solid (NH4)2SO4 and gentle stirring over 45 min. This mixture was centrifuged (27,000 × g, 15 min), and the supernatant was taken to 50% (NH4)2SO4 saturation at 4 °C by slow addition of solid (NH4)2SO4 with gentle stirring over 45 min. This mixture was centrifuged as before, and the resulting pellet was stored at -70 °C. The 20-50% (NH4)2SO4 pellet was thawed, resuspended in 10 ml of loading buffer, and dialyzed (12,000-14,000 molecular weight cut-off) for 12 h at 4 °C against 4 liters of loading buffer to exchange out (NH4)2SO4 from the solution. This was then passed through a 0.45-µm filter and loaded onto a Protein-Pak DEAE HR 8-µm 1000 Å column (20 × 100 mm) (Waters). The ThiF/ThiS protein mixture was purified by gradient elution (flow rate was 4 ml/min). The column with bound protein was washed with loading buffer for 10 min and then taken from 0% elution buffer (50 mM Tris, 2 mM DTT, 2 mM EDTA, 1 M NaCl, pH 7.5) to 30% elution buffer over 70 min. Under these conditions, ThiF and ThiS eluted together at 15% elution buffer, suggesting that ThiS is bound to ThiF. The ThiFS-containing fractions were identified by SDS-PAGE analysis, pooled, concentrated, exchanged into gel filtration buffer (50 mM Tris, 2 mM DTT, 2 mM EDTA, 20 mM NaCl) using a YM10 Amicon ultrafiltration membrane, and loaded onto a Superdex 75 gel filtration column (Amersham Pharmacia Biotech). At a flow rate of 1.2 ml/min, ThiF and ThiS again eluted together after 1.5 h. The ThiFS-containing fractions were identified by SDS-PAGE analysis and pooled, concentrated, and exchanged into 50 mM Tris, 2 mM DTT, pH 7.5, using a YM10 Amicon ultrafiltration membrane (Millipore). The protein solution was diluted by adding glycerol to 10% and frozen at a final concentration of 16 mg/ml until use. SDS-PAGE analysis of the purification is shown in Fig. 4A.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 4.   SDS-PAGE gel of ThiFS purifications. Molecular mass standard positions are given on the left side of both panels. A, SDS-PAGE gel analysis of ThiFS/BL21(DE3). Lane 1, crude extract; lane 2, 20-50% (NH4)2SO4 fraction; lane 3, DEAE eluent; lane 4, Superdex 75 eluent. B, SDS-PAGE gel analysis of ThiFS/VJS2890(DE3). Lane 1, crude extract; lane 2, 20-50% (NH4)2SO4 fraction; lane 3, DEAE eluent; lane 4, Superdex 75 eluent.

Overexpression and Purification of ThiFS from E. coli VJS2890(DE3) (thiI-)-- The purification of ThiFS from E. coli VJS2890(DE3) (thiI-) was identical to the purification of ThiFS from E. coli BL21(DE3) (thiI+). SDS-PAGE analysis of the purification is shown in Fig. 4B.

Pyrophosphate Assay-- Pyrophosphate was assayed using the Enz-Chek pyrophosphate assay kit (27). The assay volume was 1 ml. The reaction buffer was 20 mM Tris-HCl, 1 mM MgCl2, pH 7.5. 75 µl of ThiFS isolated from BL21(DE3) (thiI+) (approximate concentration 16 mg/ml; the molar ratio of ThiF to ThiS was not determined) was added to initiate the reaction. ATP was added to a concentration of 2.5 mM. Assays were run for 1 min.

Mass Spectrometric Detection of a Covalent ThiS-AMP Adduct-- Reaction buffer (50 µl, 10 mM ATP, 10 mM MgCl2, 50 mM Tris, 2 mM DTT, pH 7.5) was added to ThiFS (25 µl of a 16 mg/ml solution) isolated from E. coli VJS2890(DE3) (thiI-) incubated at 25 °C for 10 min and then acidified to pH 3 by addition of glacial acetic acid (2 µl). The assay mixture was diluted with water (100 µl) and loaded onto a reverse-phase peptide trap (Michrom BioResources, Inc.). The trap was washed with 1 ml of 98% H2O/1% MeOH/1% acetic acid, and the protein was eluted with 150 µl of 80% methanol/20% acetic acid (the first 50 µl was discarded). 2 µl of this eluent was loaded into a borosilicate glass capillary (1.5 mm inner diameter) pulled to a 2-µm tip at one end (28). A platinum wire inserted into the distal end of the glass capillary made contact with the solution and a voltage of 0.7-1.4 kV on the wire determined the flow rate (approx 25-75 nl/min). Droplets formed by ESI were sampled by the heated metal capillary (approx 110 °C) of a 6T Fourier transform mass spectrometer described previously (29, 30). Briefly, ions are guided through five stages of differential pumping by a skimmer and three quadrupole ion guides into the magnet bore held at 10-9 torr. Ions of interest were isolated in the trapped ion cell by the stored wave form inverse Fourier transform (SWIFT) technique (31) and collisionally activated by sustained off-resonance irradiation (SORI) (32) in the presence of approx 10-6 torr N2.

Mass Spectrometric Detection of ThiS Thiocarboxylate-- ThiFS (25 µl, 16 mg/ml), isolated from E. coli BL21(DE3) (thiI+) was thawed and acidified to pH 3 by the addition of glacial acetic acid (2 µl). The mixture was diluted with water (100 µl) and loaded onto a reverse-phase peptide trap (Michrom BioResources, Inc.). The trap was washed with 1 ml of 98% H2O/1% MeOH/1% acetic acid, and the protein was eluted with 150 µl of 80% methanol/20% acetic acid (the first 50 µl was discarded). 2 µl of this eluent was loaded into a borosilicate glass capillary and electrosprayed as described above. ThiFS isolated from E. coli VJS2890(DE3) (thiI-) was analyzed in an identical manner.

Iodoacetic Acid Derivatization of ThiS Thiocarboxylate-- ThiFS (25 µl, 16 mg/ml) isolated from E. coli BL21(DE3) (thiI+) was thawed, and iodoacetic acid was added (25 µl of a 10 mM solution in 25 mM Tris, pH 7.5). This mixture was incubated for 5 min at 25 °C and then acidified to pH 3 by addition of glacial acetic acid (2 µl). The mixture was diluted with water (100 µl) and loaded onto a reverse-phase peptide trap (Michrom BioResources, Inc.). The trap was washed with 1 ml of 98% H2O/1% MeOH/1% acetic acid, and the protein was eluted with 150 µl of 80% methanol/20% acetic acid (the first 50 µl was discarded). 2 µl of this eluent was loaded into a borosilicate glass capillary and electrosprayed as described above.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Purification of ThiFS-- The purification of ThiFS is summarized in Fig. 4. Both of the ThiFS overexpression strains provided high levels of soluble protein. The average yield of purified (>90%) ThiFS was 5 mg/liter of cell culture. ThiF and ThiS copurify through several steps, demonstrating that ThiF and ThiS form a stable complex. ThiS stains poorly with Coomassie Blue and is not visible on the gel. The mass spectra discussed below clearly demonstrate its presence in all ThiFS samples examined.

Pyrophosphate Production by ThiFS Isolated from E. coli BL21(DE3) (thiI+)-- ThiFS catalyzed the formation of pyrophosphate from ATP (Fig. 5). This reaction required Mg2+ as a cofactor. Pyrophosphate production reached a plateau, presumably because of the complete consumption of ThiS, after the formation of approximately 23 nmol pyrophosphate. If the ratio of ThiF:ThiS was 1:1, 35 nmol of pyrophosphate would be expected. This suggests that the ThiF:ThiS stoichiometry is 1:0.66, and that during purification 34% of ThiS dissociates from the ThiF. It was not possible to determine whether ThiF on its own would catalyze the hydrolysis of ATP because overexpression of ThiF in the absence of ThiS gave only inclusion bodies. The overexpression of ThiS using the pET-16B vector was also unsuccessful.


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 5.   Pyrophosphate production assay results. Partially purified (>90%) ThiFS/BL21(DE3) was assayed for formation of pyrophosphate as described under "Experimental Procedures." bullet , ~35 µM ThiFS + 2.5 mM ATP; open circle , 2.5 mM ATP.

Mass Spectrometric Detection of a Covalent ThiS-AMP Adduct-- The ESI/FTMS of ATP-treated ThiFS isolated from E. coli VJS2890(DE3) (thiI-) is shown in Fig. 6. In addition to showing ions that can be assigned to [ThiS]5+ (m/z = 1463.15), the spectrum shows ions at m/z = 1528.97 that can be assigned to [ThiS-COAMP]5+.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   ESI/FTMS detection of a covalent ThiS-AMP adduct. ThiFS/VJS2890(DE3) (thiI-) and ATP were incubated together and then analyzed by ESI/FTMS as described under "Experimental Procedures." Spectrum showing [ThiS]5+ and [ThiS-COAMP]5+. The inset shows isotopic resolution of [ThiS-COAMP]5+.

Mass Spectrometric Characterization of ThiS Isolated from E. coli BL21(DE3) (thiI+) and from E. coli VJS2890(DE3) (thiI-)-- ESI/FTMS on ThiFS isolated from E. coli BL21(DE3) (thiI+) demonstrated that the predominant ThiS ion had an additional mass of 16 Da compared with ThiS isolated from E. coli VJS2890(DE3) (thiI-) (Fig. 7, A and B, respectively). This is consistent with the replacement of one oxygen with sulfur on the protein. The ratio of ThiS to ThiS+16 in the (thiI+) sample was approximately 1:9. SWIFT isolation and SORI activation of the [ThiS+16]6+ ions gave 10 fragment ions; two of these had masses of 7235.64 and 7178.69 and were assigned as b65 and b64 ions (fragments that contain the NH2 terminus of the protein) (33). These represent the loss of 91 Da (COOH-terminal glycine + 16 Da) and 148 Da (COOH-terminal glycine + 16 Da + internal glycine), respectively, from the COOH terminus of the ThiS+16 adduct and strongly suggested that the COOH-terminal glycine carboxylate of ThiS has been converted to a thiocarboxylate in the (thiI+) strain (Fig. 8).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 7.   ESI/FTMS characterization of the ThiS+16 adduct. ThiFS/BL21(DE3) (thiI+) and ThiFS/VJS2890(DE3) (thiI-) were purified and analyzed by ESI/FTMS as described under "Experimental Procedures." A, spectrum showing isotopic resolution of [ThiS]6+, [ThiS+16]6+, and [ThiS+16+Na]6+ from ThiFS/BL21(DE3) (thiI+). B, spectrum showing isotopic resolution of [ThiS]6+ and also showing [ThiF]22+ (not isotopically resolved) from ThiFS/VJS2890(DE3) (thiI-).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 8.   ESI/FTMS sequencing of the ThiS+16 adduct. A, fragment ions resulting from SWIFT isolation and SORI activation of [ThiS+16]6+ from ThiFS/BL21(DE3) (thiI+). B, COOH-terminal structure of ThiS+16 protein showing cleavage sites of b64 and b65 ions. The COOH-terminal amino acid fragments leave as neutrals.

To confirm this, ThiFS from E. coli BL21(DE3) (thiI+) was alkylated with iodoacetic acid. Analysis of the reaction mixture by ESI/FTMS demonstrated the formation of a new species with mass of 7384.70-4, corresponding to [ThiS+16-H+CH2COOH] (Fig. 9A). SWIFT isolation of the 6+ charge state of the sodium adduct at m = 7406.7 (formed in a separate sample ionization), followed by SORI activation gave a series of 5+ fragments (Fig. 9B). All of these fragments were assigned either as b ions or y ions (fragments that contain the COOH terminus of the protein) (33). All of the observed b ions through b63 had a mass identical to that predicted from the unmodified ThiS sequence, and the y62, y63, and y64 ions (sodium adducts) all contained the modified amino acid. This localized the site of modification to the carboxyl-terminal Ala64, Gly65, and Gly66 residues (Fig. 9C). Because the only functional group in these three residues is the Gly66 carboxylate, ThiS isolated from E. coli BL21(DE3) (thiI+) must contain a thiocarboxylate at the COOH terminus.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 9.   ESI/FTMS characterization of the ThiS+16 adduct derivatized with iodoacetic acid. ThiFS/BL21(DE3) (thiI+) was incubated with iodoacetic acid, worked up, and analyzed by ESI/FTMS as described under "Experimental Procedures." A, spectrum showing isotopic resolution of [ThiS]6+, [ThiS+16]6+, [ThiS+16+58]6+, and [ThiS+16+58+Na]6+. B, b ions and y ions resulting from SWIFT isolation and SORI activation of [ThiS+16+58+Na]6+. C, amino acid sequence of ThiS. The marks between amino acids indicate the fragmentation pattern observed in panel B.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

The sequence similarity between ThiF/ThiS and the ubiquitin-activating enzyme E1/ubiquitin suggested that ThiF might catalyze the adenylation of ThiS and that ThiS might be the sulfur carrier in thiamin biosynthesis. In addition, the dual role of ThiI in both thiazole biosynthesis and in sulfur transfer in 4-thiouridine biosynthesis in tRNA suggested that ThiI may play a role in the sulfur transfer to ThiS. The high level overexpression of soluble ThiFS from E. coli BL21(DE3) (thiI+) and from E. coli VJS2890(DE3) (thiI-) and the partial purification of these proteins (>90%) has made it possible to test these hypotheses (Fig. 3).

When ThiFS isolated from E. coli BL21(DE3) (thiI+) was incubated with ATP, a rapid initial burst of pyrophosphate formation was observed (Fig. 5). The reaction then stops presumably because of the complete conversion of ThiS to ThiS-COAMP. It was possible to directly detect this species using ESI/FTMS (Fig. 6). This demonstrates that ThiF catalyzes the adenylation of ThiS on an oxygen nucleophile.

Analysis of ThiFS isolated from E. coli BL21(DE3) (thiI+) by ESI/FTMS demonstrated the presence of a ThiS+16 adduct as the major form of isolated ThiS (Fig. 7A). This could be because of methionine oxidation during isolation or to the replacement of an oxygen by sulfur. Partial sequencing of ThiS+16 (Fig. 8) and the product resulting from alkylation of ThiS+16 by iodoacetate (Fig. 9A) unambiguously identified the +16 adduct as an oxygen to sulfur replacement and uniquely localized the site of modification to the carboxylic acid group of the carboxyl-terminal glycine residue.

MS analysis of ThiS isolated from E. coli VJS2890(DE3) (thiI-) demonstrated that the ThiS-COSH was not formed in this strain (Fig. 7B). This suggests that ThiI plays an essential role in the conversion of ThiS-COAMP to ThiS-COSH.

The detection of ThiS-COSH was surprising. None of the previous mechanistic proposals for the formation of the thiazole moiety of thiamin predicted the existence of such an intermediate (1).

The mechanistic enzymology of the sulfur transfer chemistry involved in the biosynthesis of thiamin, molybdopterin, biotin, and lipoic acid is still poorly understood. The immediate sulfur source for the formation of biotin and lipoic acid is unknown, and the mechanism of the sulfur insertion chemistry is not yet clear (34-38). The sulfur transfer chemistry involved in thiamin and molybdopterin biosynthesis is likely to be similar. A three-enzyme system (MoeB, MoaD, and MoaE) for the sulfur transfer to precursor Z in molybdopterin biosynthesis has been reconstituted (39). ThiF and MoeB (GenBankTM accession number 127233) show high sequence similarity, and both MoaD (GenBankTM accession number 2507065) and ThiS contain the carboxyl-terminal GG residues and bind sulfur as a thiocarboxylate (20, 40). With the identification of the immediate sulfur donor in thiamin biosynthesis and the development of an overexpression strain yielding milligram quantities of ThiS-COSH,6 it should now be possible to reconstitute the biosynthesis of the thiazole moiety. Efforts along these lines are in progress.

    FOOTNOTES

* This work was supported by Grants DK44083 (to T. P. B.) and GM16609 (to F. W. M.) from the National Institutes of Health, a fellowship from the ACS Analytical Chemistry Division sponsored by the Perkin-Elmer Corp. (to N. L. K.), a National Institutes of Health Training Grant (to S. V. T. and N. L. K.), and a National Science Foundation Fellowship (to C. L. K.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed.

1 This compound has also been referred to as 1-deoxy-D-threo-2-pentulose-5-phosphate.

2 C. Kinsland and T. P. Begley, unpublished results.

3 Mueller, E. G., Buck, C. J., Palenchar, P. M., Barnhart, L. E., and Paulson, J. L. (1998) Nucleic Acids Res., in press.

4 Kelleher, N. L., Taylor, S. V., Grannis, D., Kinsland, C., Chiu, H.-J., Begley, T. P., and McLafferty, F. W. (1998) Protein Sci., in press.

5 The abbreviations used are: PAGE, polyacrylamide gel electrophoresis; ESI/FTMS, electrospray ionization Fourier transform mass spectrometry; DTT, dithiothreitol; SWIFT, stored wave form inverse Fourier transform; SORI, sustained off-resonance irradiation; PCR, polymerase chain reaction; ThiS-COAMP, C-terminal carboxy adenylated ThiS.

6 Kinsland, C., Taylor, S. V., Kelleher, N. L., McLafferty, F. W., and Begley, T. P. (1998) Protein Sci., in press.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Begley, T. P. (1996) Nat. Prod. Rep. 13, 177-186[CrossRef][Medline] [Order article via Infotrieve]
  2. Estramareix, B., and David, S. (1996) New J. Chem. 20, 607-629
  3. Spenser, I. D., and White, R. L. (1997) Angew. Chem. Int. Ed. Engl. 36, 1032-1046[CrossRef]
  4. Himmeldirk, K., Sayer, B. G., and Spenser, I. D. (1998) J. Am. Chem. Soc. 120, 3581-3589[CrossRef]
  5. Estramareix, B., and David, S. (1990) Biochim. Biophys. Acta 1035, 154-160[Medline] [Order article via Infotrieve]
  6. Estramareix, B., and David, S. (1986) Biochem. Biophys. Res. Commun. 134, 1136-1141[CrossRef][Medline] [Order article via Infotrieve]
  7. Tazuya, K., Tanaka, M., Morisaki, M., Yamada, K., and Kumaoka, H. (1987) Biochem. Int. 14, 769-777
  8. Estramareix, B., and Therisod, M. (1972) Biochim. Biophys. Acta 273, 275-282[Medline] [Order article via Infotrieve]
  9. Bellion, E., Kirkley, D. H., and Faust, J. R. (1976) Biochim. Biophys. Acta 437, 229-237[Medline] [Order article via Infotrieve]
  10. White, R. H., and Rudolph, F. B. (1978) Biochim. Biophys. Acta 542, 340-347[Medline] [Order article via Infotrieve]
  11. Tazuya, K., Yamada, K., Nakamura, K., and Kumaoka, H. (1987) Biochim. Biophys. Acta 924, 210-215[Medline] [Order article via Infotrieve]
  12. DeMoll, E., and Shive, W. (1985) Biochem. Biophys. Res. Commun. 132, 217-222[CrossRef][Medline] [Order article via Infotrieve]
  13. David, S., Estramareix, B., Fischer, J. C., and Therisod, M. (1982) J. Chem. Soc. Perkin Trans. I 2131-2137
  14. Sprenger, G. A., Schörken, U., Wiegert, T., Grolle, S., de Graaf, A. A., Taylor, S. V., Begley, T. P., Bringer-Meyer, S., and Sahm, H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12857-12862[Abstract/Free Full Text]
  15. Vander Horn, P. B., Backstrom, A. D., Stewart, V., and Begley, T. P. (1993) J. Bacteriol. 175, 982-992[Abstract/Free Full Text]
  16. Backstrom, A. D., McMordie, R. A. S., and Begley, T. P. (1995) J. Am. Chem. Soc. 117, 2351-2352[CrossRef]
  17. Webb, E., Claas, K., and Downs, D. M. (1997) J. Bacteriol. 179, 4399-4402[Abstract/Free Full Text]
  18. Lipsett, M. (1972) J. Biol. Chem. 247, 1458-1461[Abstract/Free Full Text]
  19. Ryals, J., Hsu, R. Y., Lipsett, M. N., and Bremer, H. (1982) J. Bacteriol. 151, 899-904[Abstract/Free Full Text]
  20. Rajagopalan, K. V. (1997) Biochem. Soc. Trans. 25, 757-761[Medline] [Order article via Infotrieve]
  21. Blattner, F. R., Burland, V., Plunkett, G., III, Sofia, H. J., and Daniels, D. L. (1993) Nucleic Acids Res. 21, 5408-5417[Abstract/Free Full Text]
  22. Laemmli, U. K. (1970) Nature 227, 680-685[CrossRef][Medline] [Order article via Infotrieve]
  23. Stewart, G. S. A. B., Lubinsky-Mink, S., Jackson, C. G., Cassel, A., and Kuhn, J. (1986) Plasmid 15, 172-181[CrossRef][Medline] [Order article via Infotrieve]
  24. Stewart, V., and Parales, J., Jr. (1988) J. Bacteriol. 170, 1589-1597[Abstract/Free Full Text]
  25. Winans, S. C., Elledge, S. J., Krueger, J. H., and Walker, G. C. (1985) J. Bacteriol. 161, 1219-1221[Abstract/Free Full Text]
  26. Miller, J. H. (1972) Experiments in Molecular Genetics, p. 433, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  27. Webb, M. R. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 4884-4887[Abstract/Free Full Text]
  28. Wilm, M., and Mann, M. (1994) Int. J. Mass Spectrom. Ion Proc. 136, 167-180[CrossRef]
  29. Beu, S. C., Senko, M. W., Quinn, J. P., Wampler, F. M. I., and McLafferty, F. W. (1993) J. Am. Soc. Mass Spectrom. 4, 557-565[CrossRef]
  30. McLafferty, F. W. (1994) Acc. Chem. Res. 27, 379-386[CrossRef]
  31. Marshall, A. G., Wang, T. C. L., and Ricca, T. L. (1985) J. Am. Chem. Soc. 107, 7893-7897[CrossRef]
  32. Gauthier, J. W., Trautman, T. R., and Jacobsen, D. B. (1991) Anal. Chim. Acta 246, 211-225[CrossRef]
  33. Roepstorff, P., and Fohlman, J. (1984) Biomed. Mass Spectrom. 11, 601[CrossRef][Medline] [Order article via Infotrieve]
  34. Sanyal, I., Cohen, G., and Flint, D. H. (1994) Biochemistry 33, 3625-3631[CrossRef][Medline] [Order article via Infotrieve]
  35. Sanyal, I., Gibson, K. J., and Flint, D. H. (1996) Arch. Biochem. Biophys. 326, 48-56[CrossRef][Medline] [Order article via Infotrieve]
  36. Florentin, D., Tse Sum Bui, B., Marquet, A., Ohshiro, T., and Izumi, Y. (1994) C. R. Acad. Sci. Paris 317, 485-488
  37. Hayden, M. A., Huang, I., Bussiere, D. E., and Ashley, G. W. (1992) J. Biol. Chem. 267, 9512-9515[Abstract/Free Full Text]
  38. Reed, K. E., and Cronan, J. E., Jr. (1993) J. Bacteriol. 175, 1325-1336[Abstract/Free Full Text]
  39. Pitterle, D. M., Johnson, J. L., and Rajagopalan, K. V. (1993) J. Biol. Chem. 268, 13506-13509[Abstract/Free Full Text]
  40. Pitterle, D. M., and Rajagopalan, K. V. (1993) J. Biol. Chem. 268, 13499-13505[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Kriek, F. Martins, R. Leonardi, S. A. Fairhurst, D. J. Lowe, and P. L. Roach
Thiazole Synthase from Escherichia coli: AN INVESTIGATION OF THE SUBSTRATES AND PURIFIED PROTEINS REQUIRED FOR ACTIVITY IN VITRO
J. Biol. Chem., June 15, 2007; 282(24): 17413 - 17423.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Xu, J. Zhang, L. Wang, J. Zhou, H. Huang, J. Wu, Y. Zhong, and Y. Shi
Solution structure of Urm1 and its implications for the origin of protein modifiers
PNAS, August 1, 2006; 103(31): 11625 - 11630.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Shigi, Y. Sakaguchi, T. Suzuki, and K. Watanabe
Identification of Two tRNA Thiolation Genes Required for Cell Growth at Extremely High Temperatures
J. Biol. Chem., May 19, 2006; 281(20): 14296 - 14306.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
B. Teusink, F. H. J. van Enckevort, C. Francke, A. Wiersma, A. Wegkamp, E. J. Smid, and R. J. Siezen
In Silico Reconstruction of the Metabolic Pathways of Lactobacillus plantarum: Comparing Predictions of Nutrient Requirements with Those from Growth Experiments
Appl. Envir. Microbiol., November 1, 2005; 71(11): 7253 - 7262.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
J. Eichler and M. W. W. Adams
Posttranslational Protein Modification in Archaea
Microbiol. Mol. Biol. Rev., September 1, 2005; 69(3): 393 - 425.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. F. Brady, C. J. Chao, and J. Clardy
Long-Chain N-Acyltyrosine Synthases from Environmental DNA
Appl. Envir. Microbiol., November 1, 2004; 70(11): 6865 - 6870.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
M. A. Pysz, S. B. Conners, C. I. Montero, K. R. Shockley, M. R. Johnson, D. E. Ward, and R. M. Kelly
Transcriptional Analysis of Biofilm Formation Processes in the Anaerobic, Hyperthermophilic Bacterium Thermotoga maritima
Appl. Envir. Microbiol., October 1, 2004; 70(10): 6098 - 6112.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. C. Martinez-Gomez, M. Robers, and D. M. Downs
Mutational Analysis of ThiH, a Member of the Radical S-Adenosylmethionine (AdoMet) Protein Superfamily
J. Biol. Chem., September 24, 2004; 279(39): 40505 - 40510.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Leonardi and P. L. Roach
Thiamine Biosynthesis in Escherichia coli: IN VITRO RECONSTITUTION OF THE THIAZOLE SYNTHASE ACTIVITY
J. Biol. Chem., April 23, 2004; 279(17): 17054 - 17062.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
R. Leipuviene, Q. Qian, and G. R. Bjork
Formation of Thiolated Nucleosides Present in tRNA from Salmonella enterica serovar Typhimurium Occurs in Two Principally Distinct Pathways
J. Bacteriol., February 1, 2004; 186(3): 758 - 766.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Tao and L. Tong
Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease
J. Biol. Chem., August 15, 2003; 278(33): 31372 - 31379.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. M. Wuebbens and K. V. Rajagopalan
Mechanistic and Mutational Studies of Escherichia coli Molybdopterin Synthase Clarify the Final Step of Molybdopterin Biosynthesis
J. Biol. Chem., April 11, 2003; 278(16): 14523 - 14532.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Rodionov, A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand
Comparative Genomics of Thiamin Biosynthesis in Procaryotes. NEW GENES AND REGULATORY MECHANISMS
J. Biol. Chem., December 6, 2002; 277(50): 48949 - 48959.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Miranda-Rios, M. Navarro, and M. Soberon
A conserved RNA structure (thi box) is involved in regulation of thiamin biosynthetic gene expression in bacteria
PNAS, July 19, 2001; (2001) 161168098.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Xi, Y. Ge, C. Kinsland, F. W. McLafferty, and T. P. Begley
Biosynthesis of the thiazole moiety of thiamin in Escherichia coli: Identification of an acyldisulfide-linked protein-protein conjugate that is functionally analogous to the ubiquitin/E1 complex
PNAS, June 28, 2001; (2001) 141226698.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
G. C. McGhee and A. L. Jones
Complete Nucleotide Sequence of Ubiquitous Plasmid pEA29 from Erwinia amylovora Strain Ea88: Gene Organization and Intraspecies Variation
Appl. Envir. Microbiol., November 1, 2000; 66(11): 4897 - 4907.
[Abstract] [Full Text]


Home page
J. Bacteriol.Home page
J. Gralnick, E. Webb, B. Beck, and D. Downs
Lesions in gshA (Encoding gamma -L-Glutamyl-L-Cysteine Synthetase) Prevent Aerobic Synthesis of Thiamine in Salmonella enterica Serovar Typhimurium LT2
J. Bacteriol., September 15, 2000; 182(18): 5180 - 5187.
[Abstract] [Full Text]


Home page